Centessa Pharmaceuticals Plc (CNTA)
39.42
-0.02
(-0.06%)
USD |
NASDAQ |
Apr 30, 16:00
39.42
0.00 (0.00%)
After-Hours: 16:54
Centessa Pharmaceuticals Total Liabilities (Quarterly) : 163.34M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 10.83B |
| Eli Lilly & Co. | 85.94B |
| Apellis Pharmaceuticals, Inc. | 705.11M |
| Roivant Sciences Ltd. | 251.14M |
| Silence Therapeutics Plc | 69.14M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 690.20M |
| Shareholders Equity (Quarterly) | 526.86M |
| Debt to Equity Ratio | 0.2247 |
| Current Ratio | 8.568 |
| Net Debt Paydown Yield | -0.18% |